AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DIHYDROARTEMISININ
8 registrations across 3 African markets— 5 active
Markets with DIHYDROARTEMISININ
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Combimal Capsule Capsules Otc 1X12 | 🇳🇬Nigeria | Grace Drugs And Healthcare Ltd 1a | expired | Jan 2021 |
| ALAXIN 60MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2008 |
| ALAXIN-SUSPENSION 160MG/80ML ORAL SUSPENSION ORAL SUSPENSION | 🇲🇼Malawi | — | expired | Jun 2008 |
| Dihydroartemisinin | 🌍WW | CR San Jiu (You Yang) Pharmaceutical Co., Ltd | active | — |
| Dihydroartemisinin | 🌍WW | Guilin Pharmaceutical Co., Ltd. | active | — |
| Dihydroartemisinin | 🌍WW | Mangalam Drugs and Organics Ltd | active | — |
| Dihydroartemisinin | 🌍WW | Ipca Laboratories Ltd | active | — |
| Dihydroartemisinin | 🌍WW | CR San Jiu (You Yang) Pharmaceutical Co., Ltd | active | — |
DIHYDROARTEMISININ in Africa — Regulatory Overview
DIHYDROARTEMISININ is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including WW, Malawi, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 5 (63%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.